338 related articles for article (PubMed ID: 9311915)
1. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.
Tamura Y; Peng P; Liu K; Daou M; Srivastava PK
Science; 1997 Oct; 278(5335):117-20. PubMed ID: 9311915
[TBL] [Abstract][Full Text] [Related]
2. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease.
Wang XY; Kazim L; Repasky EA; Subjeck JR
Int J Cancer; 2003 Jun; 105(2):226-31. PubMed ID: 12673684
[TBL] [Abstract][Full Text] [Related]
3. Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study.
Janetzki S; Palla D; Rosenhauer V; Lochs H; Lewis JJ; Srivastava PK
Int J Cancer; 2000 Oct; 88(2):232-8. PubMed ID: 11004674
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice.
Sato K; Torimoto Y; Tamura Y; Shindo M; Shinzaki H; Hirai K; Kohgo Y
Blood; 2001 Sep; 98(6):1852-7. PubMed ID: 11535521
[TBL] [Abstract][Full Text] [Related]
5.
Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
Front Immunol; 2019; 10():454. PubMed ID: 30967859
[TBL] [Abstract][Full Text] [Related]
6. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.
Wang XY; Sun X; Chen X; Facciponte J; Repasky EA; Kane J; Subjeck JR
J Immunol; 2010 Jun; 184(11):6309-19. PubMed ID: 20439916
[TBL] [Abstract][Full Text] [Related]
7. Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.
Qian J; Hong S; Wang S; Zhang L; Sun L; Wang M; Yang J; Kwak LW; Hou J; Yi Q
Blood; 2009 Oct; 114(18):3880-9. PubMed ID: 19654406
[TBL] [Abstract][Full Text] [Related]
8. Natural autoantibodies against heat-shock proteins hsp70 and gp96: implications for immunotherapy using heat-shock proteins.
Ménoret A; Chandawarkar RY; Srivastava PK
Immunology; 2000 Nov; 101(3):364-70. PubMed ID: 11106940
[TBL] [Abstract][Full Text] [Related]
9. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory.
Dai J; Liu B; Caudill MM; Zheng H; Qiao Y; Podack ER; Li Z
Cancer Immun; 2003 Jan; 3():1. PubMed ID: 12747743
[TBL] [Abstract][Full Text] [Related]
10. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.
Wang XY; Chen X; Manjili MH; Repasky E; Henderson R; Subjeck JR
Cancer Res; 2003 May; 63(10):2553-60. PubMed ID: 12750279
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation.
Weng D; Song B; Koido S; Calderwood SK; Gong J
J Immunol; 2013 Jul; 191(2):755-63. PubMed ID: 23772032
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.
Chang CL; Tsai YC; He L; Wu TC; Hung CF
Cancer Res; 2007 Oct; 67(20):10047-57. PubMed ID: 17942939
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein--peptide complexes as immunotherapy for human cancer.
Przepiorka D; Srivastava PK
Mol Med Today; 1998 Nov; 4(11):478-84. PubMed ID: 9857367
[TBL] [Abstract][Full Text] [Related]
14. Induction of leukemia-specific antibodies by immunotherapy with leukemia-cell-derived heat shock protein 70.
Jimbo J; Sato K; Hosoki T; Shindo M; Ikuta K; Torimoto Y; Kohgo Y
Cancer Sci; 2008 Jul; 99(7):1427-34. PubMed ID: 18452562
[TBL] [Abstract][Full Text] [Related]
15. Recombinant heat shock protein 70 functional peptide and alpha-fetoprotein epitope peptide vaccine elicits specific anti-tumor immunity.
Wang XP; Wang QX; Lin HP; Xu B; Zhao Q; Chen K
Oncotarget; 2016 Nov; 7(44):71274-71284. PubMed ID: 27713135
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein-peptide complexes in cancer immunotherapy.
Srivastava PK; Udono H
Curr Opin Immunol; 1994 Oct; 6(5):728-32. PubMed ID: 7826528
[TBL] [Abstract][Full Text] [Related]
17. Autologous Hsp70 immunization induces anti-tumor immunity and increases longevity and survival of tumor-bearing mice.
Kumar S; Deepak P; Acharya A
Neoplasma; 2009; 56(3):259-68. PubMed ID: 19309230
[TBL] [Abstract][Full Text] [Related]
18. Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.
Rivoltini L; Castelli C; Carrabba M; Mazzaferro V; Pilla L; Huber V; Coppa J; Gallino G; Scheibenbogen C; Squarcina P; Cova A; Camerini R; Lewis JJ; Srivastava PK; Parmiani G
J Immunol; 2003 Oct; 171(7):3467-74. PubMed ID: 14500642
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.
Kim MT; Richer MJ; Gross BP; Norian LA; Badovinac VP; Harty JT
J Immunol; 2015 Nov; 195(9):4537-44. PubMed ID: 26408669
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the treatment effect on melanoma by heat shock protein 70-peptide complexes purified from human melanoma cell lines.
Gao Y; Gao W; Chen X; Cha N; Wang X; Jia X; Wang B; Ren M; Ren J
Oncol Rep; 2016 Sep; 36(3):1243-50. PubMed ID: 27431432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
